Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Comparison of risperidone and methylphenidate for reducing ADHD symptoms in children and adolescents with moderate mental retardation.

Correia Filho AG, Bodanese R, Silva TL, Alvares JP, Aman M, Rohde LA.

J Am Acad Child Adolesc Psychiatry. 2005 Aug;44(8):748-55.

PMID:
16034276
2.
3.

National survey of adherence, efficacy, and side effects of methylphenidate in children with attention-deficit/hyperactivity disorder in Taiwan.

Gau SS, Chen SJ, Chou WJ, Cheng H, Tang CS, Chang HL, Tzang RF, Wu YY, Huang YF, Chou MC, Liang HY, Hsu YC, Lu HH, Huang YS.

J Clin Psychiatry. 2008 Jan;69(1):131-40.

PMID:
18312048
4.

Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders.

Abikoff H, McGough J, Vitiello B, McCracken J, Davies M, Walkup J, Riddle M, Oatis M, Greenhill L, Skrobala A, March J, Gammon P, Robinson J, Lazell R, McMahon DJ, Ritz L; RUPP ADHD/Anxiety Study Group.

J Am Acad Child Adolesc Psychiatry. 2005 May;44(5):418-27.

PMID:
15843763
5.
6.

Ginkgo biloba for attention-deficit/hyperactivity disorder in children and adolescents: a double blind, randomized controlled trial.

Salehi B, Imani R, Mohammadi MR, Fallah J, Mohammadi M, Ghanizadeh A, Tasviechi AA, Vossoughi A, Rezazadeh SA, Akhondzadeh S.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):76-80. doi: 10.1016/j.pnpbp.2009.09.026. Epub 2009 Oct 5.

PMID:
19815048
7.

Switching from methylphenidate immediate release to MPH-SODAS in attention-deficit/hyperactivity disorder.

Maia CR, Matte BC, Ludwig HT, Rohde LA.

Eur Child Adolesc Psychiatry. 2008 Apr;17(3):133-42.

PMID:
17846812
8.

Risperidone augmentation for treatment-resistant aggression in attention-deficit/hyperactivity disorder: a placebo-controlled pilot study.

Armenteros JL, Lewis JE, Davalos M.

J Am Acad Child Adolesc Psychiatry. 2007 May;46(5):558-65.

PMID:
17450046
9.

Reboxetine versus methylphenidate in treatment of children and adolescents with attention deficit-hyperactivity disorder.

Arabgol F, Panaghi L, Hebrani P.

Eur Child Adolesc Psychiatry. 2009 Jan;18(1):53-9. doi: 10.1007/s00787-008-0705-9. Epub 2008 Jun 18.

PMID:
18563471
11.
12.

A randomized, double-blind, placebo-controlled, parallel-group study of methylphenidate transdermal system in pediatric patients with attention-deficit/hyperactivity disorder.

Findling RL, Bukstein OG, Melmed RD, López FA, Sallee FR, Arnold LE, Pratt RD.

J Clin Psychiatry. 2008 Jan;69(1):149-59. Erratum in: J Clin Psychiatry. 2008 Feb;69(2):329.

PMID:
18312050
13.

A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder.

Rösler M, Fischer R, Ammer R, Ose C, Retz W.

Eur Arch Psychiatry Clin Neurosci. 2009 Mar;259(2):120-9. doi: 10.1007/s00406-008-0845-4. Epub 2009 Jan 22. Erratum in: Eur Arch Psychiatry Clin Neurosci. 2009 Sep;259(6):368.

PMID:
19165529
14.

Buspirone versus methylphenidate in the treatment of attention deficit hyperactivity disorder: a double-blind and randomized trial.

Davari-Ashtiani R, Shahrbabaki ME, Razjouyan K, Amini H, Mazhabdar H.

Child Psychiatry Hum Dev. 2010 Dec;41(6):641-8. doi: 10.1007/s10578-010-0193-2.

PMID:
20517641
15.

Is age-at-onset criterion relevant for the response to methylphenidate in attention-deficit/hyperactivity disorder?

Reinhardt MC, Benetti L, Victor MM, Grevet EH, Belmonte-de-Abreu P, Faraone SV, Rohde LA.

J Clin Psychiatry. 2007 Jul;68(7):1109-16.

PMID:
17685750
16.

Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.

Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK.

Clin Ther. 2007 Jun;29(6):1168-77.

PMID:
17692731
18.

A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.

Stein MA, Sarampote CS, Waldman ID, Robb AS, Conlon C, Pearl PL, Black DO, Seymour KE, Newcorn JH.

Pediatrics. 2003 Nov;112(5):e404.

PMID:
14595084
19.

A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in children with attention-deficit/hyperactivity disorder.

Wigal S, Swanson JM, Feifel D, Sangal RB, Elia J, Casat CD, Zeldis JB, Conners CK.

J Am Acad Child Adolesc Psychiatry. 2004 Nov;43(11):1406-14.

PMID:
15502600
20.

Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs.

Snyder R, Turgay A, Aman M, Binder C, Fisman S, Carroll A; Risperidone Conduct Study Group.

J Am Acad Child Adolesc Psychiatry. 2002 Sep;41(9):1026-36.

PMID:
12218423

Supplemental Content

Support Center